Pugilistic Vanda Collects Another NOOH As US FDA Defends Tradipitant Turndown

Can Vanda revive its bid for tradipitant after the FDA revealed its case for refusing approval? (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Complete Response Letters

More from Pathways & Standards